Allied Market Research recently published a report, titled, “Ankylosing Spondylitis Market by Drug Class (NSAIDs, TNF Inhibitors and Others), and Distribution Channel (Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy): Global Opportunity Analysis and Industry Forecast, 2021–2030.” As per the report, the global ankylosing spondylitis industry was accounted for $5.14 billion in 2020, and is expected to reach $8.11 billion by 2030, growing at a CAGR of 4.6% from 2021 to 2030.
“Alarming rise in prevalence of ankylosing spondylitis, improvement in healthcare infrastructure, rise in number of hospitals, and advancement in ankylosing spondylitis therapy are expected to notably contribute toward the growth of the global ankylosing spondylitis market during the forecast period.”
Ankylosing spondylitis is a chronic inflammatory disease that affects the spine. It is a type of arthritis, in which spine bones grow or fuse together, causing the spine to become rigid. Symptoms of ankylosing spondylitis include pain and stiffness from the neck to the lower back, bony fusion, and pain in the ligaments and tendons. These symptomatic changes may be mild or severe, and may lead to a stooped-over posture.Increase in the number of hospitals and diagnostic centers, rise in prevalence of ankylosing spondylitis, and growing advancements in the ankylosing spondylitis treatment have boosted the growth of the global market.
𝐅𝐨𝐫 𝐑𝐢𝐠𝐡𝐭 𝐏𝐞𝐫𝐬𝐩𝐞𝐜𝐭𝐢𝐯𝐞 𝐚𝐧𝐝 𝐂𝐨𝐦𝐩𝐞𝐭𝐢𝐭𝐢𝐯𝐞 𝐈𝐧𝐬𝐢𝐠𝐡𝐭𝐬, 𝐆𝐞𝐭 𝐒𝐚𝐦𝐩𝐥𝐞 𝐑𝐞𝐩𝐨𝐫𝐭 𝐚𝐭 : https://www.alliedmarketresearch.com/request-sample/10631
The cause of ankylosing spondylitis is not discovered yet, however it has been linked with a gene called HLA-B27. It has been observed that some patients are carrying same gene i.e. HLA-B27. Ankylosing spondylitis can be diagnosed via X-rays of the back and pelvis; or by physical examination.
𝐂𝐨𝐯𝐢𝐝-19 𝐬𝐜𝐞𝐧𝐚𝐫𝐢𝐨 –
– The outbreak of covid-19 impacted the ankylosing spondylitis market. Due to the medical emergency during the first and second wave of the pandemic, hospitals were struggling to manage and treat huge number of covid patients with limited capacity. Thus, many surgeries were postponed.
– As there was high risk of spreading of covid infections many orthopedic surgeries were canceled or postponed.
𝐊𝐞𝐲 𝐩𝐥𝐚𝐲𝐞𝐫𝐬-
1. Eli Lilly and Company
2. AbbVie, Inc,
3. Gilead Sciences
4. Amgen, Inc,
5. Merck & Co. Inc
6. UCB, Inc.,
7. Pfizer, Inc
8. Janssen Pharmaceuticals
9. Reliance Life Sciences Pvt. Ltd
10. Novartis AG
𝐃𝐨 𝐘𝐨𝐮 𝐇𝐚𝐯𝐞 𝐀𝐧𝐲 𝐐𝐮𝐞𝐫𝐲 𝐎𝐫 𝐒𝐩𝐞𝐜𝐢𝐟𝐢𝐜 𝐑𝐞𝐪𝐮𝐢𝐫𝐞𝐦𝐞𝐧𝐭? 𝐀𝐬𝐤 𝐭𝐨 𝐎𝐮𝐫 𝐈𝐧𝐝𝐮𝐬𝐭𝐫𝐲 𝐄𝐱𝐩𝐞𝐫𝐭: https://www.alliedmarketresearch.com/purchase-enquiry/10631
Region-wise, the ankylosing spondylitis market is analyzed across North America (U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and Rest of Europe), Asia-Pacific (Japan, China, Australia, India, South Korea, and Rest of Asia-Pacific), and LAMEA (Brazil, South Arabia, South Africa, and LAMEA).
Factors that drive the growth of the ankylosing spondylitis market include rise in number of hospitals, increase in ankylosing spondylitis patients and advancement in ankylosing spondylitis treatment and surgery. For instance, according to World Health Organization (WHO), in 2021, musculoskeletal conditions are the leading contributor to disability worldwide, with low back pain being the single leading cause of disability in 160 countries. Furthermore, rise in awareness about ankylosing spondylitis contributes toward growth of the ankylosing spondylitis market.
On the basis of drug class, the market is divided into NSAIDs, TNF inhibitors and others. The NSAIDs segment dominated the market in 2020, and this trend is expected to continue during the forecast period, owing to increase in number patients suffering from ankylosing spondylitis and high reliability of product.
On the basis of drug class, the market is divided into NSAIDs, TNF inhibitors and others. The NSAIDs segment dominated the market in 2020, and this trend is expected to continue during the forecast period, owing to increase in number patients suffering from ankylosing spondylitis and high reliability of product.
𝐁𝐲 𝐑𝐞𝐠𝐢𝐨𝐧
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, Spain, Rest of Europe)
Asia-Pacific (Japan, China, Australia, India, South Korea, Rest of Asia Pacific)
LAMEA (Brazil, Saudi Arabia, South Africa, Rest of LAMEA)
𝐅𝐑𝐄𝐐𝐔𝐄𝐍𝐓𝐋𝐘 𝐀𝐒𝐊𝐄𝐃 𝐐𝐔𝐄𝐒𝐓𝐈𝐎𝐍𝐒?
Q1. What is the total market value of Ankylosing spondylitis market report ?
Q2. What would be forecast period in the market report?
Q3. What is the market value of Ankylosing spondylitis market in 2021?
Q4. Which is base year calculated in the Ankylosing spondylitis market report?
Q5. Does the ankylosing spondylitis company is profiled in the report?
Q6. Which are the top companies hold the market share in Ankylosing spondylitis market?
Q7. What are the market values / growth % of emerging countries?
Q8. What are the key trends in the Ankylosing spondylitis market report?
𝐋𝐨𝐨𝐤𝐢𝐧𝐠 𝐟𝐨𝐫 𝐂𝐮𝐬𝐭𝐨𝐦𝐢𝐳𝐚𝐭𝐢𝐨𝐧? 𝐑𝐞𝐪𝐮𝐞𝐬𝐭 𝐡𝐞𝐫𝐞 : https://www.alliedmarketresearch.com/request-for-customization/10631
𝐓𝐫𝐞𝐧𝐝𝐢𝐧𝐠 𝐑𝐞𝐩𝐨𝐫𝐭𝐬 𝐢𝐧 𝐇𝐞𝐚𝐥𝐭𝐡𝐜𝐚𝐫𝐞 𝐈𝐧𝐝𝐮𝐬𝐭𝐫𝐲:
- At 6.1% CAGR, Gas Chromatography Market to Garner $3.2 Bn to 2031 – AMR – https://www.alliedmarketresearch.com/body-fat-reduction-market-A10916
- All About Insulin Syringes Market Size Worth $2,401.51 Million by 2031 | CAGR 4.4% – https://www.alliedmarketresearch.com/insulin-syringes-market
- $7.15+ Billion Hospital Beds Market : Year 2022-2031 and its detail analysis by Focusing on Top Key Players – https://www.alliedmarketresearch.com/request-sample/15743
- $32.4+ Billion Scar Treatment Market Size to Exhibit CAGR of 9.4% by 2031 – https://www.alliedmarketresearch.com/scar-treatment-market-A13439
- Human Papillomavirus Vaccine Market Revenue to Cross $10.8 Billion by 2031 – https://www.alliedmarketresearch.com/human-papillomavirus-vaccine-market-A14328
- Increasing demand for Hearing Amplifiers Market Worth $123.81 Mn, Globally, by 2030 at 4.5+% CAGR – https://www.alliedmarketresearch.com/hearing-amplifiers-market-A10990